SS

Shailendra Singh Rawat

Director DIN 06743849
DIN 06743849 First appointment Jan 2014
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Shailendra Singh Rawat

Data last updated:

Shailendra Singh Rawat was a Director at Elsin Pharmaceuticals Private Limited (from 2017) and Director at Erwin Healthcare Private Limited (from 2014).

DIN 06743849
First Appointment 22 Jan 2014
Oldest Company Age 12 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Dec 20172017Strike Off
Erwin Healthcare Private Limited U51101DL2014PTC263849
Director22 Jan 20142014₹12,068 (FY 2021)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Elsin Pharmaceuticals Private Limited
Erwin Healthcare Private Limited
Premium access

Shareholding and investment profile for Shailendra Singh Rawat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shailendra Singh Rawat

Shailendra Singh Rawat was first appointed on 22 Jan 2014 as Director at Erwin Healthcare Private Limited. The most recent appointment on record is 13 Dec 2017 at Elsin Pharmaceuticals Private Limited.

Shailendra Singh Rawat held 2 earlier board appointments: Elsin Pharmaceuticals Private Limited (Director, from 13 Dec 2017); Erwin Healthcare Private Limited (Director, from 22 Jan 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available